- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GSK
Recent news which mentions GSK
Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
September 28, 2021
From Benzinga
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
From Benzinga
Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism
September 27, 2021
From Benzinga
2 Best Biotech Stocks to Buy Right Now
September 25, 2021
From Motley Fool
Why Vir Biotechnology Stock Is Sinking This Week
September 24, 2021
From Motley Fool
Green Hygienics Holdings To Raise $100M Via Green Bond Offering
September 22, 2021
From Benzinga
Here's Why I Bought This Recent Genetics IPO
September 22, 2021
From Motley Fool
Here's Why Moderna's Stock Could Crash Before the End of 2021
September 19, 2021
From Motley Fool
5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch
September 18, 2021
From Motley Fool
7 SPACs to Buy That Are Better Than Bill Ackman’s Pershing Square Tontine
September 15, 2021
From InvestorPlace
Why Are Theravance Bio Shares Plummeting Premarket Today?
September 15, 2021
From Benzinga
3 Stocks I Bought That Could Produce 10X Returns
September 15, 2021
From Motley Fool
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
From Benzinga
Pete Najarian Sees Unusual Options Activity In Capri Holdings And GlaxoSmithKline
September 13, 2021
From Benzinga
These Promising Clinical Results Could Be Huge for Amgen Investors
September 11, 2021
From Motley Fool
Could This Be Pfizer's Next Blockbuster Vaccine?
September 10, 2021
From Motley Fool
Here's the Next Blockbuster Vaccine Opportunity for Pfizer
September 10, 2021
From Motley Fool
Why Alector Shares Are Diving Today
September 08, 2021
From Motley Fool
White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report
September 03, 2021
From Benzinga
Can Vaccine Help In Long Term COVID-19 Symptoms? UK Study Gives Encouraging Answer
September 02, 2021
From Benzinga
Now May Be the Big Moment for These 2 COVID Stocks
September 02, 2021
From Motley Fool
From Benzinga
3 Things About Pfizer That Smart Investors Know
August 31, 2021
From Motley Fool
The 7 Best Stocks to Buy for September
August 30, 2021
From InvestorPlace
This Biotech Company Could Offer Nearly Unlimited Optionality
August 28, 2021
From Motley Fool
Boston Omaha and Latch: 2 Small Caps Worth a Look
August 27, 2021
From Motley Fool
From Benzinga
Better Healthcare Stock: Johnson & Johnson vs. Pfizer
August 26, 2021
From Motley Fool
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
August 24, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.